GenHenn Venture logo

GenHenn Venture

North America, New Jersey, United States, Cranbury

Description

GenHenn Capital is a single-family office that specializes in private equity and venture capital investments

Investor Profile

GenHenn Venture has backed more than 7 startups, with 3 new investments in the last 12 months alone. The firm has led 1 rounds, about 14% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series B rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Health Care, Biotechnology, Medical.

Stage Focus

  • Series A (71%)
  • Series B (29%)

Country Focus

  • United States (100%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Medical Device
  • Life Science
  • Nutraceutical
  • Computer
  • Industrial Manufacturing
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does GenHenn Venture frequently co-invest with?

Cancer Prevention and Research Institute of Texas
North America, Texas, United States, Austin
Co-Investments: 1
Quest Diagnostics
North America, New Jersey, United States, Secaucus
Co-Investments: 2
LabCorp
North America, North Carolina, United States, Burlington
Co-Investments: 2
Eventide
North America, Massachusetts, United States, Boston
Co-Investments: 2
KEEN Growth Capital
North America, Florida, United States, Windermere
Co-Investments: 1
Colorcon
North America, Pennsylvania, United States, Harleysville
Co-Investments: 1
S2G Ventures
North America, Illinois, United States, Chicago
Co-Investments: 1
iSelect Fund
North America, Missouri, United States, St Louis
Co-Investments: 1
Touchdown Ventures
North America, New Jersey, United States, Haddonfield
Co-Investments: 1
Alumni Ventures
North America, New Hampshire, United States, Manchester
Co-Investments: 1

What are some of recent deals done by GenHenn Venture?

PreciseDx

New York, New York, United States

PreciseDx is the only Cancer Risk Stratification company to provide patient-specific risk information through the analysis of morphology.

Health Care
Series BJun 5, 2025
Amount Raised: $11,230,074
Sonavex

Baltimore, Maryland, United States

Sonavex is a developer of an imaging technology designed to visualize and quantify critical data to detect anastomotic blood clots.

BiotechnologyHealth CareMedical
Series AOct 24, 2024
Amount Raised: $15,000,000
PreciseDx

New York, New York, United States

PreciseDx is the only Cancer Risk Stratification company to provide patient-specific risk information through the analysis of morphology.

Health Care
Series BAug 21, 2024
Amount Raised: $20,700,000
Prana Thoracic

Houston, Texas, United States

Prana Thoracic is a medical devices company that develops solutions for the early detection and intervention of lung cancer.

Health CareMedicalMedical Device
Series AJun 18, 2024
Amount Raised: $3,000,000
MEND

New York, New York, United States

MEND is a life sciences company that focuses on clinical nutrition and medical foods.

BiotechnologyHealth CareLife ScienceNutraceutical
Series AJun 6, 2023
Amount Raised: $15,000,000
Diligent Pharma

Philadelphia, Pennsylvania, United States

Diligent Pharma is a platform that streamlines the selection and qualification of clinical trial service providers.

ComputerIndustrial ManufacturingPharmaceutical
Series AMay 15, 2023
Amount Raised: $8,270,000
Xenocor

Salt Lake City, Utah, United States

Xenocor offers a suite of leading edge, fog-free, single-use endoscopes for minimally invasive surgical procedures.

Medical Device
Series AApr 18, 2023
Amount Raised: $10,000,000